Search results (7)
« Back to News from COICOVID-19 Impact Report
20 January 2023
The CAMS-Oxford Institute (COI) has funded 12 COVID-19 projects aiming to understand immune responses to COVID-19, contributing nearly 100 published research articles to the field. Read about the impact the COI has had on our understanding of COVID-19 pathology and immunology.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
COVID Without Borders: Diagnostics and Treatment for COVID-19
18 December 2020
CAMS-Oxford Joint Symposiums COVID Seminars
The CAMS-COI Joint webinar entitled “COVID Without Borders-A collaboration to Investigate A New Disease III – Diagnostic and Treatment for COVID-19” was held online on the morning of November 17th 2020.
Oxford University breakthrough on global COVID-19 vaccine
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
COVID Without Borders: Vaccine Research and Development
15 October 2020
CAMS-Oxford Joint Symposiums COVID Seminars
The webinar entitled “COVID Without Borders: A collaboration to Investigate a New Disease II - Vaccine Research and Development” was held online on 22nd September 2020.
COVID Without Borders: A collaboration to Investigate A New Disease
21 July 2020
CAMS-Oxford Joint Symposiums COVID Seminars
On the morning of 1st July 2020, the webinar “COVID Without Borders: A collaboration to Investigate A New Disease” was held online.
COI prioritise funding support to the current crisis caused by novel coronavirus
6 February 2020
The CAMS Oxford Institute has prioritised funding support in response to the current crisis caused by nCoV 2019, supporting positive actions taken by the Medical Sciences Divisions and University of Oxford.